Baltimore Bayview biologics plant
Syngene USA Inc. (Syngene International), Baltimore, Baltimore city County, Maryland
Baltimore Bayview biologics plant in Baltimore, Maryland is Syngene USA Inc. (Syngene International)’s plant for monoclonal antibody biologics. Status: announced as of August 11, 2025. Syngene USA Inc. (Syngene International) announced $50 million and 300 jobs. Primary source: commerce.maryland.gov, checked November 12, 2026.
- Status
- Announced
- Announced investment
- $50 million
- Announced jobs
- 300
- Industry
- Pharmaceuticals
- Sheet
- MD-13
- Revised
- November 12, 2026
Status timeline
- Announcedcommerce.maryland.gov
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Syngene USA Inc. (Syngene International) |
|---|---|
| Plant | Baltimore Bayview biologics plant |
| Location | Baltimore, Baltimore city County, Maryland |
| Industry | Pharmaceuticals |
| Product | Monoclonal antibody biologics |
| Announced investment | $50 million$36.5 million acquisition plus $13.5 million planned renovations |
| Announced jobs | 300 |
| Last checked | November 12, 2026 |
Sources
- Maryland Commerce: Syngene International pharmaceutical manufacturing facility in Baltimore City (state release, commerce.maryland.gov, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.